{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:37:22Z","timestamp":1792255042812,"version":"4.4.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T00:00:00Z","timestamp":1589673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>An important issue in current oncological research is prevention as well as early detection of cancer. This includes also the difficulty to predict the progression of early or pre-cancerous lesions to invasive cancer. In this context, the characterization and categorization of pre-neoplastic lesions of squamous cell carcinoma [cervical intraepithelial neoplasia (CIN)] are an important task with major clinical impact. Screening programs are worldwide established with the aim to detect and eradicate such lesions with the potential to develop untreated into cervical cancer. From the literature it is known that around 5% of CIN 2 and 12% of CIN 3 cases will progress to cancer. The use of molecular markers extracted from cervical mucus might help to identify these high-risk cases and to exclude unnecessary biopsies or surgical treatment. Here we can show that micro RNA (miRNA) analysis from cervical mucus of 49 patients allowed us to distinguish between healthy patients and patients with CIN 3. The miRNA panel used in combination allowed for highly significant testing (P &amp;lt; 0.0001) of CIN 3 status. In parallel, the human papillomavirus status of the patients, the most important factor for the development of cervical cancer, significantly correlated with the miRNA markers hsa-miR-26b-5p, hsa-miR-191-5p and hsa-miR-143-3p, a subpanel of the original six miRNAs. We provide here a proof-of-concept for cervical mucus-based testing for pre-neoplastic stages of cervical squamous cell carcinoma.<\/jats:p>","DOI":"10.1093\/carcin\/bgaa046","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T07:49:44Z","timestamp":1589356184000},"page":"1781-1789","source":"Crossref","is-referenced-by-count":13,"title":["The use of micro RNA in the early detection of cervical intraepithelial neoplasia"],"prefix":"10.1093","volume":"41","author":[{"given":"Julia","family":"Wittenborn","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonore","family":"Weikert","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Hangarter","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital RWTH, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Stickeler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-3128","authenticated-orcid":false,"given":"Jochen","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,17]]},"reference":[{"issue":"Pt 2","key":"2021010806304550400_CIT0001","first-page":"727","article-title":"Natural history of cervical squamous intraepithelial lesions: a meta-analysis","volume":"92","author":"Melnikow","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"2021010806304550400_CIT0002","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2021010806304550400_CIT0003","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"2021010806304550400_CIT0004","doi-asserted-by":"crossref","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses"},{"key":"2021010806304550400_CIT0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"key":"2021010806304550400_CIT0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(14)70073-7","article-title":"Filling a gap in cervical cancer screening programmes","volume":"15","author":"Wentzensen","year":"2014","journal-title":"Lancet. Oncol."},{"key":"2021010806304550400_CIT0007","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1073\/pnas.0511045103","article-title":"Cell-type-specific signatures of microRNAs on target mRNA expression","volume":"103","author":"Sood","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021010806304550400_CIT0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2012.07.058","article-title":"A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis","volume":"508","author":"De Felice","year":"2012","journal-title":"Gene"},{"key":"2021010806304550400_CIT0009","doi-asserted-by":"crossref","first-page":"e66709","DOI":"10.1371\/journal.pone.0066709","article-title":"miRNA signature of mouse helper T cell hyper-proliferation","volume":"8","author":"Sommers","year":"2013","journal-title":"PLoS One"},{"key":"2021010806304550400_CIT0010","doi-asserted-by":"crossref","first-page":"16138","DOI":"10.1038\/s41598-018-34604-3","article-title":"Identifying a miRNA signature for predicting the stage of breast cancer","volume":"8","author":"Yerukala Sathipati","year":"2018","journal-title":"Sci. Rep."},{"key":"2021010806304550400_CIT0011","doi-asserted-by":"crossref","first-page":"81670","DOI":"10.18632\/oncotarget.13164","article-title":"Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"2021010806304550400_CIT0012","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/molecules21101307","article-title":"miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Vis."},{"key":"2021010806304550400_CIT0013","doi-asserted-by":"crossref","DOI":"10.3390\/microarrays5030018","article-title":"MicroRNA profile of lung tumor tissues is associated with a high risk plasma miRNA signature","volume":"5","author":"Fortunato","year":"2016","journal-title":"Microarrays"},{"key":"2021010806304550400_CIT0014","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cancergen.2017.07.006","article-title":"Potential circulating miRNA signature for early detection of NSCLC","volume":"216\u2013217","author":"Arab","year":"2017","journal-title":"Cancer Genet."},{"key":"2021010806304550400_CIT0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1476-4598-13-202","article-title":"The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases","volume":"13","author":"Leidinger","year":"2014","journal-title":"Mol. Cancer"},{"key":"2021010806304550400_CIT0016","doi-asserted-by":"crossref","first-page":"e0150154","DOI":"10.1371\/journal.pone.0150154","article-title":"Urinary exosomal miRNA signature in type II diabetic nephropathy patients","volume":"11","author":"Deli\u0107","year":"2016","journal-title":"PLoS One"},{"key":"2021010806304550400_CIT0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12885-015-1190-4","article-title":"Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker","volume":"15","author":"Erbes","year":"2015","journal-title":"BMC Cancer"},{"key":"2021010806304550400_CIT0018","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/bmm.13.44","article-title":"Stability of miRNA in human urine supports its biomarker potential","volume":"7","author":"Mall","year":"2013","journal-title":"Biomark. Med."},{"key":"2021010806304550400_CIT0019","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ijc.29618","article-title":"A systematic study on dysregulated microRNAs in cervical cancer development","volume":"138","author":"He","year":"2016","journal-title":"Int. J. Cancer"},{"key":"2021010806304550400_CIT0020","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1038\/s41598-018-25310-1","article-title":"Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia","volume":"8","author":"Kawai","year":"2018","journal-title":"Sci. Rep."},{"key":"2021010806304550400_CIT0021","doi-asserted-by":"crossref","first-page":"15700","DOI":"10.3390\/ijms150915700","article-title":"Multistep model of cervical cancer: participation of miRNAs and coding genes","volume":"15","author":"Granados L\u00f3pez","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"2021010806304550400_CIT0022","doi-asserted-by":"crossref","first-page":"4903152","DOI":"10.1155\/2019\/4903152","article-title":"MicroRNAs as potential biomarkers for chemoresistance in adenocarcinomas of the esophagogastric junction","volume":"2019","author":"Just","year":"2019","journal-title":"J. Oncol."},{"key":"2021010806304550400_CIT0023","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/or.2012.2105","article-title":"Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma","volume":"29","author":"Yang","year":"2013","journal-title":"Oncol. Rep."},{"key":"2021010806304550400_CIT0024","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2016.05.007","article-title":"miRNA-126 orchestrates an oncogenic program in B cell precursor acute lymphoblastic leukemia","volume":"29","author":"Nucera","year":"2016","journal-title":"Cancer Cell"},{"key":"2021010806304550400_CIT0025","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","author":"Murakami","year":"2006","journal-title":"Oncogene"},{"key":"2021010806304550400_CIT0026","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.4161\/cc.21278","article-title":"Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm","volume":"11","author":"Cheung","year":"2012","journal-title":"Cell Cycle"},{"key":"2021010806304550400_CIT0027","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.2016.179","article-title":"Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer","volume":"115","author":"Miyamoto","year":"2016","journal-title":"Br. J. Cancer"},{"key":"2021010806304550400_CIT0028","doi-asserted-by":"crossref","first-page":"24383","DOI":"10.18632\/oncotarget.8328","article-title":"Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"2021010806304550400_CIT0029","article-title":"MiR-143-3p suppresses cell proliferation, migration, and invasion by targeting melanoma-associated antigen A9 in laryngeal squamous cell carcinoma","author":"Han","year":"2018","journal-title":"J. Cell. Biochem"},{"key":"2021010806304550400_CIT0030","first-page":"2276","article-title":"miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells","volume":"9","author":"Li","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"2021010806304550400_CIT0031","first-page":"866","article-title":"MiR-143-3p suppresses the progression of ovarian cancer","volume":"10","author":"Shi","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"2021010806304550400_CIT0032","first-page":"1686","article-title":"MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma","volume":"15","author":"Chen","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"2021010806304550400_CIT0033","doi-asserted-by":"crossref","first-page":"2058738418790318","DOI":"10.1177\/2058738418790318","article-title":"Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma","volume":"32","author":"Chen","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"2021010806304550400_CIT0034","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13046-019-1079-1","article-title":"MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop","volume":"38","author":"Luo","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2021010806304550400_CIT0035","doi-asserted-by":"crossref","first-page":"57174","DOI":"10.18632\/oncotarget.19170","article-title":"MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma","volume":"8","author":"Bozec","year":"2017","journal-title":"Oncotarget"},{"key":"2021010806304550400_CIT0036","first-page":"9584","article-title":"Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer","volume":"15","author":"Yoshikawa","year":"2018","journal-title":"Oncol. Lett."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgaa046\/33390384\/bgaa046.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/41\/12\/1781\/35528241\/bgaa046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/41\/12\/1781\/35528241\/bgaa046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T16:45:24Z","timestamp":1610556324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/41\/12\/1781\/5838417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,17]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,5,17]]},"published-print":{"date-parts":[[2020,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgaa046","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,5,17]]}}}